Taiwan negotiates price cuts for HIV drugs
This article was originally published in Scrip
Executive Summary
Following several months of direct discussions with manufacturers, Taiwan's Centers for Disease Control (CDC) has secured price reductions for a basket of antiretroviral drugs for HIV/AIDS that it provides free to patients under a universal access program.